NUCOMAT

NUCOMAT has been active since 1988 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.1m and a net result of €229,133. Equity remains stable across the filed financial years (±0.1% per year). Its solvency ranks better than 74% of 3,354 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).